Hirotoshi Watanabe

About Hirotoshi Watanabe

Hirotoshi Watanabe, With an exceptional h-index of 19 and a recent h-index of 17 (since 2020), a distinguished researcher at Kyoto University, specializes in the field of Interventional Cardiology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Aspirin for Primary Prevention

Aspirin for Primary Prevention: The Importance of the Regional Difference of Drug Effect

Dexmedetomidine versus haloperidol for sedation of non-intubated patients with hyperactive delirium during the night in a high dependency unit: study protocol for an open-label …

TCT-21 Preferred Strategy in the Era of Short-Term Dual Antiplatelet Therapy: A Systematic Review and Network Meta-analysis of Randomized Trials

Acute coronary syndrome after liver transplantation in a young primary biliary cholangitis recipient with dyslipidemia: a case report

Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan―From the CREDO-Kyoto Registry Cohort-2 and Cohort-3―

Overview of the 84th Annual Scientific Meeting of the Japanese Circulation Society―Change Practice!―

Patient selection and clinical outcomes in the STOPDAPT-2 trial: an all-comer single-center registry during the enrollment period of the STOPDAPT-2 randomized controlled trial

Hirotoshi Watanabe Information

University

Position

Department of Cardiovascular Medicine Graduate School of Medicine

Citations(all)

1898

Citations(since 2020)

1763

Cited By

200

hIndex(all)

19

hIndex(since 2020)

17

i10Index(all)

31

i10Index(since 2020)

27

Email

University Profile Page

Google Scholar

Hirotoshi Watanabe Skills & Research Interests

Interventional Cardiology

Top articles of Hirotoshi Watanabe

Aspirin for Primary Prevention

2023

Hirotoshi Watanabe
Hirotoshi Watanabe

H-Index: 9

Aspirin for Primary Prevention: The Importance of the Regional Difference of Drug Effect

2023/12/1

Hirotoshi Watanabe
Hirotoshi Watanabe

H-Index: 9

Dexmedetomidine versus haloperidol for sedation of non-intubated patients with hyperactive delirium during the night in a high dependency unit: study protocol for an open-label …

BMC anesthesiology

2023/6/3

TCT-21 Preferred Strategy in the Era of Short-Term Dual Antiplatelet Therapy: A Systematic Review and Network Meta-analysis of Randomized Trials

2022/9/20

Acute coronary syndrome after liver transplantation in a young primary biliary cholangitis recipient with dyslipidemia: a case report

Surgical case reports

2022/6/17

Siyuan Yao
Siyuan Yao

H-Index: 12

Hirotoshi Watanabe
Hirotoshi Watanabe

H-Index: 9

Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan―From the CREDO-Kyoto Registry Cohort-2 and Cohort-3―

Circulation Journal

2022/4/25

Overview of the 84th Annual Scientific Meeting of the Japanese Circulation Society―Change Practice!―

Circulation Journal

2021/2/25

Patient selection and clinical outcomes in the STOPDAPT-2 trial: an all-comer single-center registry during the enrollment period of the STOPDAPT-2 randomized controlled trial

Circulation: Cardiovascular Interventions

2021/2

Hirotoshi Watanabe
Hirotoshi Watanabe

H-Index: 9

Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial

Cardiovascular intervention and therapeutics

2021/1

Hirotoshi Watanabe
Hirotoshi Watanabe

H-Index: 9

Effects of acute coronary syndrome and stable coronary artery disease on bleeding and ischemic risk after percutaneous coronary intervention

Circulation Journal

2021/10/25

Correction to: Influence of CYP2C19 genotypes for the effect of 1‑month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12‑month dual antiplatelet …

Cardiovascular Intervention and Therapeutics

2021/10/1

Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on …

Cardiovascular Intervention and Therapeutics

2021/10

Coronary revascularization in the past two decades in Japan (from the CREDO-Kyoto PCI/CABG Registries Cohort-1,-2, and-3)

The American Journal of Cardiology

2021/8/15

P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials

Journal of the American College of Cardiology

2023/2/14

Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention―From the CREDO-Kyoto Registry …

Circulation Journal

2021/5/25

Very short dual antiplatelet therapy after drug-eluting stent implantation in patients who underwent complex percutaneous coronary intervention: insight from the STOPDAPT-2 trial

Circulation

2019/12/3

Hirotoshi Watanabe
Hirotoshi Watanabe

H-Index: 9

Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk

Catheterization and Cardiovascular Interventions

2021/5/1

Changes in demographics, clinical practices and long-term outcomes of patients with ST segment-elevation myocardial infarction who underwent coronary revascularisation in the …

BMJ open

2021/3/1

Effects of Body Weight on Bleeding and Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention―From the CREDO-Kyoto Registry Cohort-2―

Circulation Journal

2020/9/25

Clopidogrel monotherapy vs. aspirin monotherapy following short-term dual antiplatelet therapy in patients receiving everolimus-eluting coronary stent implantation

Circulation Journal

2020/8/25

Hirotoshi Watanabe
Hirotoshi Watanabe

H-Index: 9

See List of Professors in Hirotoshi Watanabe University(Kyoto University)

Co-Authors

academic-engine